Emerging Worlds: Chronic Illness and Viral Infections














   
Interview with Dr. W. John Martin - MD, PhD - Lead researcher on stealth adapted viruses


Bio:
W

 

W. John Martin, M.D., Ph.D. is the founder of the Center for Complex Infectious Diseases. He has a strong commitment to the Center’s goals, especially as they relate to diagnosis and potential therapy of stealth viral illnesses.

 

John was born in Australia, where he obtained MD and Ph.D. degrees from the Universities of Sydney and Melbourne, respectively. He has had medical residency training in both Australia and the United States. He has had research training at prestigious institutions in both countries, and also in England. These include the National Institutes of Health, Harvard Medical School and University College London. He was appointed Professor of Pathology at the University of Southern California School of Medicine in July 1985. John has clinical Boards in Anatomic and Clinical Pathology with subspecialty certification in both Immunopathology and Medical Microbiology. He also has Boards in Medical Laboratory Immunology and is a Diplomat of both the American College of Forensic Examiners and the American Board of Forensic Medicine. John headed the Viral Oncology Unit within the Division of Virology, Food and Drug Administration, FDA, from 1975 to 1980. This experience sparked his interest in the safety of live viral vaccines, which is expressed today in his pursuit of vaccine-derived viral agents as causes of human illness. 

 



If you don't have the real audio player, you can download it for FREE by clicking here.


Q1. What is the nature of your work at the Center for Complex Infectious Disease?


Q2. How to you test a patient for atypical viruses?


Q3. Would you describe the symptoms of a stealth-adapted viral infection?


Q4. Can a stealth virus be any virus that adapts in this way?


Q5. How many people in the general public may be infected with stealth-adapted viruses?


Q6. How contagious are stealth-adapted viruses in humans?


Q7. Do stealth-adapted viruses spread through body fluids?


Q8. Do stealth-adapted viruses primarily attack the brain?


Q9. Do you have reason to believe children with stealth-adapted viruses could become violent?


Q10. Are stealth-adapted viruse showing up in clusters of people like families and schools?


Q11. Why haven't government agencies recognized atypical stealth-adapted viruses for further research?


Q12. What is your view on vaccines?


Q13. Are there other research groups in the world studying stealth-adapted viruses?


Q14. Are there specific factors that influence the severity of stealth-adapted viruses?


Q15. Is there a general protocol for treating stealth-adapted viruses?


Q16. What is the significance of mapping the genome to virus research?


Q17. Does the new genetic evidence suggest that viruses can be passed on from one generation to the next?


Q18. Are you seeing a general rise in viral infectious diseases?


Q19. Have you looked at the relationship between stealth-adapted viruses and cancer?


Q20. Are you accepting blood samples for testing from other physicians?


21. Is it possible the stealth adapted viruses might be involved in the mad cow outbreak?